Aligos Therapeutics (NasdaqCM:ALGS) Conference Transcript

Aligos Therapeutics (NasdaqCM:ALGS) Conference October 21, 2025 07:00 AM ET Company ParticipantsLawrence Blatt - CEOConference Call ParticipantsPatrick Trucchio - Senior Healthcare AnalystPatrick TrucchioHello everyone, and welcome to the first annual H.C. Wainwright Virtual Liver Disease Conference. My name is Patrick Trucchio. I'm a Senior Healthcare Analyst at H.C. Wainwright. This year, for the first time, we've combined our viral hepatitis and MASH conferences, expanding the scope to also include liver ...